Frazier Life Sciences Management, L.P. - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Frazier Life Sciences Management, L.P. ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$8,730,177
-2.1%
3,746,8570.0%0.58%
+8.8%
Q2 2023$8,917,520
+29.3%
3,746,8570.0%0.53%
+6.8%
Q1 2023$6,894,217
-3.2%
3,746,8570.0%0.50%
+12.6%
Q4 2022$7,119,028
-11.2%
3,746,8570.0%0.44%
-28.2%
Q3 2022$8,018,000
-24.4%
3,746,8570.0%0.62%
-38.4%
Q2 2022$10,604,000
-32.1%
3,746,8570.0%1.00%
-24.8%
Q1 2022$15,624,0003,746,8571.33%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,283,966$15,166,0001.40%
Sio Capital Management, LLC 591,870$3,930,0000.98%
TFG Asset Management GP Ltd 2,500,000$16,600,0000.90%
Ikarian Capital, LLC 1,356,048$9,004,0000.73%
SABBY MANAGEMENT, LLC 400,050$2,656,0000.37%
Nantahala Capital Management 1,793,500$11,909,0000.34%
Regency Capital Management Inc.\DE 57,000$378,0000.29%
Eversept Partners, LP 473,074$3,141,2110.21%
MYDA Advisors LLC 85,000$564,0000.14%
Henry James International Management Inc. 54,047$359,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders